11/8/26 Commercial Success in Rare Disease Takes an Ecosystem: Aligning Manufacturers, Specialty Pharmacy, Providers, and Patient Support Previous From Parent Advocacy to IND: Building a Treatment Pathway for an Ultra-Rare Disease You Might Also Like Patient Organizations as Evidence Partners: Shaping the Science Behind Rare Disease Approval Patient Input and Digital Health Technologies: A Regulatory Perspective Across the Product Lifecycle Learning More from Less: Smarter Design and Execution in Rare Disease Trials From Awareness to Activation - Converting Rare Patient Identification into Trial Enrollment From Data to Discovery: Finding the Right Patients Across the Therapy Lifecycle
11/8/26 Commercial Success in Rare Disease Takes an Ecosystem: Aligning Manufacturers, Specialty Pharmacy, Providers, and Patient Support Previous From Parent Advocacy to IND: Building a Treatment Pathway for an Ultra-Rare Disease You Might Also Like Patient Organizations as Evidence Partners: Shaping the Science Behind Rare Disease Approval Patient Input and Digital Health Technologies: A Regulatory Perspective Across the Product Lifecycle Learning More from Less: Smarter Design and Execution in Rare Disease Trials From Awareness to Activation - Converting Rare Patient Identification into Trial Enrollment From Data to Discovery: Finding the Right Patients Across the Therapy Lifecycle
